Skip to main content

Lymphangioleiomyomatosis News

Related terms: LAM, Pulmonary Lymphangioleiomyomatosis

FDA Approves Rapamune (sirolimus) for Rare Lung Disease Lymphangioleiomyomatosis

May 28, 2015 – The U.S. Food and Drug Administration today approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women of...

Ask a question

To post your own question to our community, sign in or create an account.